The New England Journal of Medicine , 384(11), 989-1002
Nuevos frmacos cmo tirzepatide una vez por semana han demostrado, en personas con DM2 y riesgo cardiovascular elevado, una reduccin mayor y clnicamente significativa de la HbA1c con una menor incidencia de hipoglucemia
A healthcare provider can offer medical advice and help determine the best option based on your needs
Should someone who wants to shed 15 vanity pounds be prioritized the same as a patient whose diabetes is damaging their kidneys
Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
Mistake 4: not labeling the vial You reconstitute a vial, put it in the fridge, and a week later you cannot remember whether you added 1mL or 2mL